Amer Saad Alali

Pharmacology, Toxicology and Pharmaceutical Science

1. Anti-Inflammatory Drug 32%
2. Apigenin 32%
3. Bioavailability 59%
4. Breast Cancer 100%
5. Captopril 32%
6. Cerebrovascular Accident 32%
7. Chitosan 98%
8. Chitosan Nanoparticle 32%
9. Chronic Kidney Failure 34%
10. Cohort Study 39%
11. Comorbidity 38%
12. Coronavirinae 32%
13. Curcumin 32%
14. Cytotoxicity 54%
15. Diarrhea 32%
16. Disease Model 32%
17. Diseases 52%
18. Drug Delivery System 32%
19. Drug Dose 32%
20. Drug Release 46%
21. Dyspnea 36%
22. Egg Lecithin 40%
23. Erectile Dysfunction 65%
24. Ethyl Cellulose 65%
25. Formulation Design 32%
26. Glycyrrhizin 32%
27. Hydroxychloroquine 32%
28. Inflammatory Arthritis 73%
29. Liposome 32%
30. Lung Cancer 38%
31. Macrogol 32%
32. Microcrystalline Cellulose 38%
33. Nanoemulsion 32%
34. Nanofiber 32%
35. Nanoparticle 40%
36. Neoplasm 32%
37. Olaparib 32%
38. Pharmacokinetic 71%
39. Rat Model 37%
40. Rheumatoid Arthritis 73%
41. Sildenafil 32%
42. Silicon Dioxide 32%
43. Sunitinib 32%
44. Systemic Lupus Erythematosus 40%
45. Tablet 40%
46. Tableting 32%
47. Tadalafil 32%
48. Vitamin D 32%
49. Wound Healing 32%
50. Zeta Potential 44%